{
  "meta": {
    "timestamp": "2025-01-06T07:10:45.229965",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Simulations Plus Inc",
      "symbol": "SLP",
      "analysis": {
        "historical": {
          "risk_score": 50,
          "key_risks": [
            "Market competition from other software providers and consulting firms",
            "Dependence on pharmaceutical R&D spending and regulatory trends",
            "Integration risks from recent acquisitions",
            "Ethical concerns related to AI/ML technologies"
          ],
          "controversies": [
            "Potential legal risks highlighted by investigations from firms like Faruqi & Faruqi, LLP",
            "Ethical questions around algorithmic bias and transparency in AI/ML applications"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Ensuring ethical AI practices to avoid discriminatory outcomes"
          ],
          "governance_issues": [
            "Need for robust AI ethics frameworks and potential establishment of an AI ethics committee"
          ],
          "recommendation": "caution",
          "confidence_score": 75
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "PDF",
              "snippet": "SIMULATIONS PLUS, INC. AUDIT COMMITTEE CHARTER Revised: March 28, 2024 ... \u2022 Company's compliance with legal and regulatory requirements; ... quality-control procedures and any material issues raised by the most recent internal quality-control review, peer review or Public Company Accounting Oversight ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.982836+00:00",
              "published_date": null,
              "source_hash": "83cf174747f86a8d7b8d26ff7413c37d"
            },
            {
              "url": "",
              "title": "Global Regulatory Strategies - Simulations Plus",
              "snippet": "Meet the requirements of global regulatory affairs and compliance to balance risk (de-risk assessment) ... The Simulations Plus Regulatory Strategies team provides: ... Simulations Plus nimbly partnered on a program to not only develop a PBPK model, but to also develop a DDI regulatory roadmap that informed our regulatory approach towards NDA ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983080+00:00",
              "published_date": null,
              "source_hash": "723fc785f8e5961a7842743555b37868"
            },
            {
              "url": "",
              "title": "Shareholder Information - Simulations Plus",
              "snippet": "The new Code of Conduct incorporates current industry and public company best practices, and was prepared to improve its readability and clarify certain areas of importance, including with respect to compliance with certain laws, conflicts of interest, insider trading, confidentiality obligations, health and environmental protections, vendor ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983140+00:00",
              "published_date": null,
              "source_hash": "2e60697b734375477186b6388193e35c"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. - 10K - Annual Report - October 30, 2024 - Fintel",
              "snippet": "Simulations Plus, Inc. was incorporated in California on July 17, 1996. ... Drug sponsors must prioritize not only efficacy of the drug, but also issues like drug-drug interactions, inclusion of diverse populations, regulatory approvals, reduction of animal testing, safety and compliance during clinical trials, and commercial success. Our model ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983154+00:00",
              "published_date": null,
              "source_hash": "25ca8c480f087105f2f9067b3f5b290a"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. ESG Risk Rating - Sustainalytics",
              "snippet": "Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983168+00:00",
              "published_date": null,
              "source_hash": "c34dba9ed4ee4b583bb68222f29225db"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. - AnnualReports.com",
              "snippet": "Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with companies to provide a data-driven, 'strategic modeling methodology', starting in early discovery, continuing through ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.709005+00:00",
              "published_date": null,
              "source_hash": "4106db75ddfe648dffe34909ca377e38"
            },
            {
              "url": "",
              "title": "SLP - Earnings call transcript Q4 2024 | Simulations Plus, Inc.",
              "snippet": "a and process in in medical analytics content regulatory confidence simulation trial As as increased regulatory in clients. both commercialization. well success success, approval provides Pro-ficiency reminder, data post-approval Ultimately, as technologies with our for AI communications, to support clinical experience developed activities ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983188+00:00",
              "published_date": null,
              "source_hash": "ff8f0147f99a6e8ad0efb4dbc4680121"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. (SLP) Company Profile & Overview - Stock Analysis",
              "snippet": "Company profile for Simulations Plus, Inc. (SLP) with a description, list of executives, contact details and other key facts. ... and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California. Simulations Plus, Inc. Country: United States ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983197+00:00",
              "published_date": null,
              "source_hash": "db13f23d79cd5c647d17d8a620defbec"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Simulation Plus, Inc. Guiding Principles of Corporate Governance Revised and Approved: Oct. 21, 2021 Simulations Plus, Inc. supports the following core guiding principles of corporate governance: 1. The Board approves corporate strategies that are intended to build sustainable long-term value;",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983207+00:00",
              "published_date": null,
              "source_hash": "727495588647bd30d174e214204e47b4"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. - ResponsibilityReports.com",
              "snippet": "Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with companies to provide a data-driven, 'strategic modeling methodology', starting in early discovery, continuing through ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:11.983217+00:00",
              "published_date": null,
              "source_hash": "b8cf57c9174af225b1b91bb2e919b330"
            },
            {
              "url": "",
              "title": "Simulations Plus (SLP) Fell due to Concerns Over the Funding Environment",
              "snippet": "Wasatch Micro-Cap Growth-U.S. Strategy highlighted stocks like Simulations Plus, Inc. (NASDAQ ... and massive growth potential. \u2022 11 New Issues of Our Premium Readership Newsletter: You will ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:15.143135+00:00",
              "published_date": "2025-01-03T08:15:00+00:00",
              "source_hash": "cd56e0ffdf551c145037d564e6e1d61b"
            },
            {
              "url": "",
              "title": "Craig-Hallum Issues a Buy Rating on Simulations Plus (SLP)",
              "snippet": "In a report released today, Matt Hewitt from Craig-Hallum assigned a Buy rating to Simulations Plus (SLP - Research Report). The company's",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:15.143235+00:00",
              "published_date": "2024-12-23T13:56:00+00:00",
              "source_hash": "5bd1d37786a46367329072a60865ae42"
            },
            {
              "url": "",
              "title": "Simulations Plus (SLP) Receives a Buy from Oppenheimer",
              "snippet": "In a report released today, Francois Brisebois from Oppenheimer reiterated a Buy rating on Simulations Plus (SLP - Research Report), with a",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:15.143254+00:00",
              "published_date": "2025-01-03T14:15:00+00:00",
              "source_hash": "7c5469a81530f3127082cfa51363907f"
            },
            {
              "url": "",
              "title": "Stephens & Co. Initiates Coverage of Simulations Plus (SLP) with Overweight Recommendation",
              "snippet": "Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:15.143268+00:00",
              "published_date": "2024-10-22T00:00:00+00:00",
              "source_hash": "f789ccf2357d18078c4b95b023e4d60c"
            },
            {
              "url": "",
              "title": "Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables",
              "snippet": "November 13, 2024--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP ... portfolios due to their ability to improve patient compliance and deliver extended drug release,\" said Dr. Daniela ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc regulatory compliance issues",
              "retrieved_at": "2025-01-06T14:10:15.143282+00:00",
              "published_date": "2024-11-14T01:42:00+00:00",
              "source_hash": "c384c7c123c4d76c0fd897a18287fa44"
            },
            {
              "url": "",
              "title": "Faruqi & Faruqi, LLP Launches An Investigation Against Simulations Plus ...",
              "snippet": "Simulations Plus. We Improve Health Through Innovative Solutions. Software. GastroPlus\u00ae MonolixSuite\u2122 ADMET Predictor\u00ae DILIsym\u00ae",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.636942+00:00",
              "published_date": null,
              "source_hash": "d30a47c49366724f4a5ac0490076d1db"
            },
            {
              "url": "",
              "title": "SEC.gov | HOME",
              "snippet": "Simulations Plus, Inc. ... This Annual Report on Form 10-K contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, concerning our business, operations, and financial performance and condition, as well as our plans, objectives, and expectations for our business operations and financial ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.637146+00:00",
              "published_date": null,
              "source_hash": "d57844104bfcb85dad56d5c18ccf9150"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. - EDGAR Online",
              "snippet": "On or about May 11, 2021, Simulations Plus, Inc., a California corporation (the \"Company\"), mailed a proxy statement (the \"Proxy Statement\") to its shareholders relating to a special meeting of the Company's shareholders (the \"Special Meeting\"), which Special Meeting is to be held on Wednesday, June 23, 2021, at 2:00 p.m. Pacific Time, virtually via live webcast through www ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.709014+00:00",
              "published_date": null,
              "source_hash": "9d795fd1ea611e5dedf74d9cf45677f1"
            },
            {
              "url": "",
              "title": "AGREEMENT AND PLAN OF MERGER by and among SIMULATIONS PLUS ...",
              "snippet": "AGREEMENT AND PLAN OF MERGER by and among SIMULATIONS PLUS, INC., COGNIGEN ACQUISITION, INC., COGNIGEN CORPORATION, THE SHAREHOLDERS' REPRESENTATIVE and THE COMPANY SHAREHOLDERS OF COGNIGENCORPORATION from SIMULATIONS PLUS INC filed with the Securities and Exchange Commission.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.637256+00:00",
              "published_date": null,
              "source_hash": "3d3c229ed7684b88cb478afd9f9ca00f"
            },
            {
              "url": "",
              "title": "SEC Filings - Simulations Plus",
              "snippet": "Cookie Duration Description; cookielawinfo-checkbox-analytics: 11 months: This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category \"Analytics\".",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.637270+00:00",
              "published_date": null,
              "source_hash": "6b6b70fa258f734553edc230e3e86d87"
            },
            {
              "url": "",
              "title": "Simulations Plus Inc | AP News",
              "snippet": "Texas' abortion pill lawsuit against New York doctor marks new challenge to interstate telemedicine; Drones, planes or UFOs? Americans abuzz over mysterious New Jersey sightings ... (AP) _ Simulations Plus Inc. (SLP) on Wednesday reported net income of $4.4 million in its fiscal second quarter. Updated [hour]:[minute] [AMPM] [timezone ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.637282+00:00",
              "published_date": null,
              "source_hash": "a5d75bd69e11da7736643080c7c603ea"
            },
            {
              "url": "",
              "title": "Simulations Plus Inc. - Filings and Transcripts - BamSEC",
              "snippet": "Simulations Plus Inc. Watch . NASDAQ: SLP Share price (12/17/24): $30.04 Market cap (12/17/24): $603 million Categorized Chronological Ownership by Owner Insider Transactions Institutional Owners Expert Interviews ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.637308+00:00",
              "published_date": null,
              "source_hash": "fe068c52dcec3e46e6076bd7d111016a"
            },
            {
              "url": "",
              "title": "Amended and Restated Employment Agreement between Simulations Plus, Inc ...",
              "snippet": "Amended and Restated Employment Agreement between Simulations Plus, Inc. and John DiBella, dated June 16, 2023. Contract Categories: Human Resources - Employment Agreements. EX-10.4 5 ex104-johndibellaaremploym.htm EX-10.4 Document. Exhibit 10.4. AMENDED AND RESTATED. EMPLOYMENT AGREEMENT.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.637333+00:00",
              "published_date": null,
              "source_hash": "f01e92081c3563a2a67ecdcdd4ac5cf6"
            },
            {
              "url": "",
              "title": "Simulations Plus: Navigating Growth and Challenges in Biosimulation",
              "snippet": "Simulations Plus, Inc. (NASDAQ: SLP) is a pivotal player in the biosimulation software and service sector, specifically tailored for the pharmaceutical research and development industry. Since its inception in 1996, the company has carved out a niche, providing vital tools and services that aid in averting costly errors and inefficiencies in ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:16.637345+00:00",
              "published_date": null,
              "source_hash": "6995c19d619bf2e4cdf98c3da9daa1bd"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. (NASDAQ:SLP) Shares Purchased by Principal Financial Group Inc.",
              "snippet": "Principal Financial Group Inc. raised its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 2.6% during the third quarter, according to the company in its most recent ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:20.188031+00:00",
              "published_date": "2025-01-04T00:00:00+00:00",
              "source_hash": "b22a85e88d897c1769f4a956a341adf7"
            },
            {
              "url": "",
              "title": "Craig-Hallum Reaffirms Their Buy Rating on Simulations Plus (SLP)",
              "snippet": "Simulations Plus (SLP) Company Description: Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:20.188101+00:00",
              "published_date": "2025-01-02T08:55:00+00:00",
              "source_hash": "ab0846c8cac94167c6797ab4c2d2db35"
            },
            {
              "url": "",
              "title": "Simulations Plus (SLP) Fell due to Concerns Over the Funding Environment",
              "snippet": "Wasatch Micro-Cap Growth-U.S. Strategy highlighted stocks like Simulations Plus, Inc. (NASDAQ:SLP) in the third quarter 2024 investor letter. Simulations Plus, Inc. (NASDAQ:SLP) focuses on the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:20.188117+00:00",
              "published_date": "2025-01-03T13:15:00+00:00",
              "source_hash": "9c0ba7ee4325895a68ae0f48a0c4caec"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. (NASDAQ:SLP) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC",
              "snippet": "Simulations Plus, Inc. has a 52 week low of $27.07 and a 52 week high of $51.22. The company has a market cap of $619.67 million, a PE ratio of 63.02 and a beta of 0.76.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Simulations Plus Inc Simulations Plus Inc litigation or lawsuits",
              "retrieved_at": "2025-01-06T14:10:20.188128+00:00",
              "published_date": "2024-12-17T00:00:00+00:00",
              "source_hash": "899072a62b138c7d687486c3abaa258f"
            },
            {
              "url": "",
              "title": "Simulations Plus: Questionable Whether Generative AI Will Hurt Or ...",
              "snippet": "Today, we put Simulations Plus, Inc. (NASDAQ:SLP) in the spotlight for the first time since our initial article on this intriguing health information services concern back in November of 2022.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.708903+00:00",
              "published_date": null,
              "source_hash": "a843c4d6f3f9b1950b818d4b92e0d9ba"
            },
            {
              "url": "",
              "title": "Simulations Plus AI and Ethics Analysis - EMBA Pro",
              "snippet": "Simulations Plus needs strong artificial intelligence ethics committee to identify and mitigate the risks, resulting out of how the algorithms are designed. Most of the discriminatory results and suggestions are not cooked in the design of the algorithms and can't be identified at the initial stages, they only appear after usage over a ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.708967+00:00",
              "published_date": null,
              "source_hash": "b086581cdc320e8526221d5b575edfb6"
            },
            {
              "url": "",
              "title": "Using Simulations Of Alleged Ethics Violations To Ardently And Legally ...",
              "snippet": "A new means to detect AI Ethics violations consists of simulating an AI system to try and detect or predict that AI Ethics violations could arise. This could be used for example in the case of AI ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.708981+00:00",
              "published_date": null,
              "source_hash": "aef24cc26c6ff14727df5ab6c899afce"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Simulations Plus, Inc. (Nasdaq: SLP), incorporated in 1996, is a premier developer of drug discovery and development software for modeling and simulation, and for the prediction of molecular properties utilizing artificial intelligence and machine learning- based technology.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.708989+00:00",
              "published_date": null,
              "source_hash": "84b0f780099252fdf20bc8a819c32c3c"
            },
            {
              "url": "",
              "title": "Corporate Profile - Simulations Plus",
              "snippet": "Simulations Plus, Inc. (NASDAQ GSM: SLP) is the leading developer of modeling and simulation software for the pharmaceutical and biotechnology industries today. ... which replaced our previous Corporate Code of Business Conduct and Ethics. The new Code of Conduct incorporates current industry and public company best practices, and was prepared ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.708997+00:00",
              "published_date": null,
              "source_hash": "58f24e408b8c5a048b94bd1d8d360e34"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. (SLP) Company Profile & Overview - Stock Analysis",
              "snippet": "Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.709034+00:00",
              "published_date": null,
              "source_hash": "6056513938103672446772a3eafa127e"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "2.3 The New Moral Science and Artificial Intelligence Gunkel (2012) may provide the most comprehensive treatment of Al ethics. He skillfully argues that moral the- ory has been indefensibly anthropocentric, resisting claims, for example, that animals and machines might warrant recognition as moral agents.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.709043+00:00",
              "published_date": null,
              "source_hash": "9cd542fcad3a4de50a82829be68572f2"
            },
            {
              "url": "",
              "title": "Simulations Plus Inc. - The New York Times",
              "snippet": "News about Simulations Plus Inc., including commentary and archival articles published in The New York Times.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:22.709051+00:00",
              "published_date": null,
              "source_hash": "86c3a8982c42d88eb72a932868932b83"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. (NASDAQ:SLP) Shares Purchased by Principal Financial Group Inc.",
              "snippet": "Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:26.240536+00:00",
              "published_date": "2025-01-04T00:00:00+00:00",
              "source_hash": "ab3a0667169e422a5c9745fe06e4c224"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. (NASDAQ:SLP) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC",
              "snippet": "Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:26.240729+00:00",
              "published_date": "2024-12-17T00:00:00+00:00",
              "source_hash": "2244d337b6ab9b5be5f5bc883df6bedb"
            },
            {
              "url": "",
              "title": "Analysts Set Simulations Plus, Inc. (NASDAQ:SLP) Target Price at $51.40",
              "snippet": "Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:26.240759+00:00",
              "published_date": "2024-12-16T00:00:00+00:00",
              "source_hash": "f66481561eb2ae3d9f9eaab19976cda5"
            },
            {
              "url": "",
              "title": "Simulations Plus, Inc. (NASDAQ:SLP) Shares Bought by Verition Fund Management LLC",
              "snippet": "Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:26.240772+00:00",
              "published_date": "2024-12-14T00:00:00+00:00",
              "source_hash": "b21e06a5a2736673310d7ab14acabb2c"
            },
            {
              "url": "",
              "title": "Simulations Plus (SLP) Fell Due to EBITDA Below Expectations",
              "snippet": "Simulations Plus, Inc. (NASDAQ:SLP) focuses on the development of drug discovery and development software that utilizes artificial intelligence and machine learning based technology for modeling ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Simulations Plus Inc Simulations Plus Inc controversies AI ethics",
              "retrieved_at": "2025-01-06T14:10:26.240781+00:00",
              "published_date": "2024-10-22T12:58:00+00:00",
              "source_hash": "cb48c1435222abd66a5670576e20d6cf"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Simulations Plus Inc regulatory compliance issues",
              "rationale": "Investigate potential legal or regulatory challenges related to drug development software and consulting services",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Simulations Plus Inc litigation or lawsuits",
              "rationale": "Identify any ongoing or past legal disputes that could impact the company's reputation or finances",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Simulations Plus Inc controversies AI ethics",
              "rationale": "Explore ethical concerns related to the use of AI and ML in drug development, including potential biases or misuse",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T07:10:45.229981",
        "data_confidence": 75,
        "pattern_confidence": null
      }
    }
  ]
}